SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
reimbursement of Medicare Part B drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| MARK COIN | — |
| EDDIE D EVANS | — |
| EDWARD GREISSING | — |
| SAIRA SULTAN | — |
Taxation/Internal Revenue Code TAX
The current protocol amending the US-French tax treaty, provisions related to withholding and mandatory arbitration; H.R. 1424 "Emergency Economic Stabilization Act of 2008" provisions related to the R&D tax credit
Foreign entity interest: Protocols amending the provisions within the US-French tax treaty impact the taxes paid by sanofi-aventis SA, the foreign parent company identified on Form LD-1.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD GREISSING | — |
| ANN TAYLOR | — |
Health Issues HCR
Issues related to awareness of and the quality of care for Deep Vein Thrombosis (DVT); standards for and funding of health information technology that would impact access to pharmaceutical care and treatment; healthcare reform that would impact the access to pharmaceutical care and treatment; issues related to the final regulations implementing those provisions of the "National Defense Authorization Act for FY 2008" related to TRICARE retail pharmacy sales.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY CLARK | — |
| MARK COIN | — |
| EDDIE D EVANS | — |
| EDWARD GREISSING | — |
| RICHARD M HODGE | — |
| SAIRA SULTAN | — |
| ANN TAYLOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.